Skip to main content
. 2016 Oct 17;10:232. doi: 10.3389/fncel.2016.00232

Figure 4.

Figure 4

Effect of a reactive oxygen species (ROS) scavenger and an nNOS inhibitor on GSK1016790A-induced neuronal injury. (A) Injection of the TRPV4 agonist GSK1016790A reduced the number of surviving cells in the hippocampal CA1 area, which was significantly attenuated by the ROS scavenger Trolox and the nNOS inhibitor ARL-17477. Scale bar = 50 μM. (B) More Hoechst+ cells (white stars) were found in the hippocampal CA1 area in the GSK1016790A-injected mice, which was markedly blocked by Trolox and ARL-17477. Scale bar = 50 μM. **P < 0.01 vs. control, ##P < 0.01 vs. GSK1016790A.